The short answer
Review high-dose vitamin D with the clinician prescribing metolazone. The label warns of infrequent high calcium, especially with high vitamin D doses; spacing is not an established solution.
What this answer covers
Oral vitamin D products, particularly high doses, with metolazone; calcium status and underlying parathyroid disease matter.
- Supplement or preparation
- Vitamin D
- Medication ingredient
- metolazone
The warning is specific to metolazone
The current label says high calcium can occur infrequently, especially in patients taking high vitamin D doses or with high bone turnover. It may also reveal previously unrecognized hyperparathyroidism. This is a reason for individualized assessment, not proof that every vitamin D dose is harmful.
Check all sources of vitamin D and calcium
Bring the dose, formulation and frequency of vitamin D, including intermittent high-dose prescriptions and combination products. Let the clinician know about calcium supplements as well. Do not assume that a supplement prescribed before metolazone needs no reassessment when treatment or health changes.
Ask about monitoring rather than a timing gap
The concern involves calcium balance, so a few hours between doses has not been established as prevention. Ask whether calcium tests or a change to high-dose treatment is appropriate. Do not stop necessary deficiency treatment or alter metolazone without the prescribing team’s advice.
Report symptoms and changes
Report persistent dizziness, cramps, weakness, palpitations or a major change in swelling or urine output. Illness, dehydration and other medicines can contribute. Severe weakness, fainting or a new irregular heartbeat need prompt assessment. Do not treat symptoms by adding salts or increasing the diuretic yourself.
Evidence and practical considerations
Timing & monitoring
High-dose vitamin D warrants clinician-directed review during metolazone because of the label’s hypercalcemia warning.
- Exact scope
- Oral vitamin D products, particularly high doses, with metolazone; calcium status and underlying parathyroid disease matter. with Exact metolazone RxCUI6916 IN, confirmed by current RxNorm. Exact metolazone oral tablets in conventional2.5/5/10mg formulation; rapidly absorbed formulations are not assumed interchangeable.
- Medication form and route
- Oral
What remains uncertain
- Exact label high-dose vitamin D warning; no universal dose threshold, automatic avoidance of replacement, or validated spacing interval.
Factors that may matter: Exact preparation and dose; Kidney function; Baseline electrolyte status; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral metolazone tablets.
Recommends electrolyte monitoring and correction if indicated; potassium loss is dose-related. Hyponatremia can be severe. Infrequent hypercalcemia especially with high vitaminD doses or high bone turnover.
How this applies: Exact medication label. Exact metolazone RxCUI6916 IN, confirmed by current RxNorm. Exact metolazone oral tablets in conventional2.5/5/10mg formulation; rapidly absorbed formulations are not assumed interchangeable.
No universal potassium/salt supplementation or fixed vitaminD gap. Other botanicals and diuretics are not automatic exact-pair evidence.
Source 2: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
metolazone is IN.
How this applies: Exact ingredient.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: a2d0af761ef8db4f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.